Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein lifeguard 1 (GRINA) is a transmembrane protein, encoded by the GRINA gene, primarily involved in negative regulation of apoptosis, especially in neurons. Although its name and some aliases suggest a direct role as a glutamate receptor, GRINA is not itself an NMDA receptor subunit but rather a receptor-associated protein with structural similarity to other BAX inhibitor motif proteins, regulating calcium homeostasis and anti-apoptotic signaling. It is mostly localized to the Golgi membrane and endoplasmic reticulum, modulating cellular responses to stress and protecting against cell death. GRINA is broadly expressed, especially in the brain, and is associated with neurological diseases such as epilepsy, autism spectrum disorder, and schizophrenia. In schizophrenia, cross-reactivity with dietary gliadin and elevated GRINA autoantibodies has been reported, implicating the protein in neuroimmune interactions and neuroinflammation
None established (as a direct drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein lifeguard 1 (GRINA).